A Study of the Relative Bioavailability of ASC18 Tablets vs Reference Tablets in Healthy Volunteers
Status:
Completed
Trial end date:
2020-12-15
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate potential drug interaction between RDV and SOF in
ASC18 tablets (RDV/SOF compound tablets) and the influence of food effect on the
pharmacokinetics of ASC18 tablets were evaluated in healthy subjects -and compare the
pharmacokinetic parameters of ASC18 tablets（ravidasvir and sofosbuvir fixed dose
combination）with ravidasvir tablets and sofosbuvir tablets in healthy subjects after single
and multiple oral dosing.